Javid Fazili

Summary

Affiliation: University of Oklahoma Health Sciences Center
Country: USA

Publications

  1. doi request reprint Outcome of a hepatitis C outbreak among patients in a pain management clinic
    Javid Fazili
    Digestive Diseases, Internal Medicine, University of Oklahoma Health Sciences Center, Williams Pavilion 1360, Oklahoma City, OK 73104, USA
    Dig Dis Sci 55:1738-43. 2010
  2. doi request reprint A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone
    Vu Le
    University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
    Nat Clin Pract Gastroenterol Hepatol 6:57-60. 2009
  3. doi request reprint Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis
    Mohammad F Madhoun
    Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, USA
    Am J Med Sci 339:169-73. 2010
  4. doi request reprint Fluvastatin inhibits hepatitis C replication in humans
    Ted Bader
    Veteran s Administration Medical Center, Oklahoma City, OK 73104, USA
    Am J Gastroenterol 103:1383-9. 2008
  5. ncbi request reprint Remission of natural-killer cell lymphoma of the liver with anti-hepatitis C therapy
    Jess F Armor
    Section of Hematology Oncology and OU cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA
    Am J Hematol 78:212-5. 2005

Collaborators

Detail Information

Publications5

  1. doi request reprint Outcome of a hepatitis C outbreak among patients in a pain management clinic
    Javid Fazili
    Digestive Diseases, Internal Medicine, University of Oklahoma Health Sciences Center, Williams Pavilion 1360, Oklahoma City, OK 73104, USA
    Dig Dis Sci 55:1738-43. 2010
    ..The aims of this study are to evaluate the natural history and response to therapy of patients following a hepatitis C outbreak in a pain management clinic...
  2. doi request reprint A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone
    Vu Le
    University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
    Nat Clin Pract Gastroenterol Hepatol 6:57-60. 2009
    ..He had been taking pegylated interferon (PEG-IFN) and ribavirin treatment for 6 weeks without any notable adverse effects. He had also been taking naproxen for 2 years for the treatment of chronic back pain...
  3. doi request reprint Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis
    Mohammad F Madhoun
    Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, USA
    Am J Med Sci 339:169-73. 2010
    ..Hepatocellular carcinoma (HCC) occurring in "noncirrhotic" hepatitis C virus (HCV)-infected patients has been reported; but the exact prevalence or incidence has not been described before...
  4. doi request reprint Fluvastatin inhibits hepatitis C replication in humans
    Ted Bader
    Veteran s Administration Medical Center, Oklahoma City, OK 73104, USA
    Am J Gastroenterol 103:1383-9. 2008
    ..Additional agents are needed to increase the cure rate. In vitro experiments show strong antiviral effects of fluvastatin against HCV...
  5. ncbi request reprint Remission of natural-killer cell lymphoma of the liver with anti-hepatitis C therapy
    Jess F Armor
    Section of Hematology Oncology and OU cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA
    Am J Hematol 78:212-5. 2005
    ..Interestingly, we observed clinical and radiologic remission of the neoplasm following treatment with anti-hepatitis C therapy...